Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
9.45B | 9.49B | 10.11B | 9.39B | 7.84B | Gross Profit |
1.73B | 1.65B | 1.95B | 1.94B | 1.39B | EBIT |
338.90M | 205.60M | 535.10M | 497.00M | 61.10M | EBITDA |
614.40M | 494.50M | 780.20M | 795.70M | 267.60M | Net Income Common Stockholders |
131.30M | -35.40M | 196.40M | 250.00M | -220.50M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
793.30M | 767.70M | 644.50M | 770.70M | 1.07B | Total Assets |
7.55B | 7.77B | 7.95B | 7.89B | 7.34B | Total Debt |
373.50M | 3.57B | 3.60B | 3.66B | 3.68B | Net Debt |
-419.80M | 2.80B | 2.95B | 2.89B | 2.61B | Total Liabilities |
5.79B | 6.10B | 6.29B | 6.44B | 6.24B | Stockholders Equity |
1.75B | 1.68B | 1.66B | 1.45B | 1.09B |
Cash Flow | Free Cash Flow | |||
208.00M | 101.20M | -1.60M | 495.70M | -79.20M | Operating Cash Flow |
208.00M | 152.20M | 49.10M | 549.50M | -38.20M | Investing Cash Flow |
81.20M | 48.90M | -120.70M | -749.50M | -257.80M | Financing Cash Flow |
-253.40M | -120.80M | -79.30M | -65.80M | 571.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | $37.16B | 37.55 | 11.61% | ― | 11.95% | -1.25% | |
68 Neutral | $8.30B | 37.15 | 14.89% | 0.26% | 13.08% | 146.40% | |
68 Neutral | $10.99B | 19.46 | 8.37% | ― | 12.87% | 142.90% | |
61 Neutral | $767.83M | 13.30 | 17.79% | 6.45% | -3.68% | 990.23% | |
61 Neutral | $4.72B | 17.64 | -3.07% | 10.89% | 5.99% | -21.86% | |
58 Neutral | $2.17B | 16.14 | 7.65% | ― | -0.50% | ― | |
46 Neutral | $162.78M | ― | -31.77% | ― | -14.70% | 1.10% |
On March 28, 2025, Cushman & Wakefield announced a proposal to change its jurisdiction of incorporation from England and Wales to Bermuda. This redomiciliation aims to reduce administrative burdens and align corporate governance with the expectations of its U.S. shareholder base. The company assures that this move will have limited impact on its operations, subsidiaries, and financial statements, maintaining its commitment to its businesses in the U.K. and Europe. The redomiciliation process requires shareholder approval and is expected to be completed in the second half of 2025.
Cushman & Wakefield announced on January 23, 2025, that they successfully repriced their Term Loan issued in June 2024, reducing the interest rate by 25 basis points to Term SOFR plus 2.75%. This financial move is part of their strategy to maintain a strong financial foundation for future growth opportunities, with all other loan terms remaining unchanged. The repricing reflects the company’s robust financial management and commitment to its stakeholders.